Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Condition:   Pulmonary Disease Due to Mycobacteria (Diagnosis) Interventions:   Drug: Amikacin;   Drug: Tigecycline;   Drug: Imipenem;   Drug: Cefoxitin;   Drug: Azithromycin;   Drug: Clarithromycin;   Drug: Clofazimine;   Drug: Ethambutol;   Drug: Linezolid;   Drug: co-trimoxazole;   Drug: Doxycycline;   Drug: Moxifloxacin;   Drug: Bedaquiline;   Drug: Rifabutin Sponsors:   The University of Queensland;   Australian Governmen...
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials

To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women
Condition:   Healthy Subjects Interventions:   Drug: Aprocitentan 25 mg;   Drug: Aprocitentan 100 mg;   Drug: Matching placebo;   Other: Moxifloxacin control to establish assay sensitivity Sponsor:   Idorsia Pharmaceuticals Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2020 Category: Research Source Type: clinical trials

A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects
Condition:   Healthy Interventions:   Drug: Daridorexant;   Drug: Placebo;   Drug: Moxifloxacin Sponsor:   Idorsia Pharmaceuticals Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2020 Category: Research Source Type: clinical trials

A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult Participants
Condition:   Healthy Participants Interventions:   Drug: Loperamide;   Other: Placebo;   Drug: Moxifloxacin Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2020 Category: Research Source Type: clinical trials

The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%
Condition:   Endophthalmitis Interventions:   Drug: Levofloxacin Ophthalmic Solution;   Drug: Moxifloxacin Ophthalmic Solution Sponsors:   National University of Malaysia;   Santen Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 2, 2020 Category: Research Source Type: clinical trials